Between January 2020 and March 2023, over 170 new oncology treatments were approved by the FDA. New approvals for the first quarter of 2023 include treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia.
Blood Cancer: Raising Awareness in BAME Communities, One Booklet at a Time
Diagnosed with chronic myeloid leukemia. After a stem cell transplant, she volunteers for awareness of blood cancer in the BAME community.
Preventing Lung Cancer | World Lung Cancer Day 2022
In support of World Lung Cancer Day 2022, we asked M3 members what actions they take to prevent lung cancer and understand cancer risk factors
How Market Research Has Contributed to Understanding Treatments for Cutaneous T Cell Lymphoma
This case study is focused on Cutaneous T Cell Lymphoma, a rare type of cancer that begins in white blood cells called T cells and affects the body’s immune system and the skin.
Oncology Developments: the Latest Opinions On Cancer Treatments
Professionals' opinion on oncology developments: CBD, Non-invasive cancer diagnosis, and remote consultation for cancer patients.